+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Glaucoma Market by Product Type, End User, Distribution Channel, Route of Administration - Global Forecast to 2030- Product Image
Glaucoma Market by Product Type, End User, Distribution Channel, Route of Administration - Global Forecast to 2030- Product Image
Sale

Glaucoma Market by Product Type, End User, Distribution Channel, Route of Administration - Global Forecast to 2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6017423
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Glaucoma Market grew from USD 7.60 billion in 2024 to USD 8.04 billion in 2025. It is expected to continue growing at a CAGR of 5.65%, reaching USD 10.57 billion by 2030.

Navigating the Future of Glaucoma Care

Glaucoma remains one of the leading causes of irreversible vision loss worldwide, driven by a convergence of demographic shifts, evolving clinical practices, and breakthroughs in diagnostic and therapeutic technologies. As populations age and screening programs expand, the need for timely detection and effective management has never been greater. This report delves into the complex dynamics that shape glaucoma care, from emerging tools that enable earlier diagnosis to minimally invasive surgical options that redefine treatment paradigms.

By exploring the interplay between patient populations, healthcare infrastructure, and industry innovation, this analysis equips decision-makers with a clear understanding of where opportunities and risks lie. Readers will discover how cross-disciplinary collaboration between device developers, pharmaceutical companies, and clinical stakeholders is fostering a new era of patient-centric care. With regulatory landscapes shifting and technology adoption accelerating, the sector stands poised at an inflection point. This introduction sets the stage for a deep dive into the transformative forces ushering in next-generation solutions for glaucoma management.

Emerging Innovations Reshaping Glaucoma Management

The glaucoma market is undergoing radical transformation as precision diagnostics, advanced surgical techniques, and novel therapeutics converge to elevate patient outcomes. Artificial intelligence-powered imaging solutions now enhance optical coherence tomography and fundus camera analyses, enabling clinicians to detect subtle structural changes long before functional loss becomes apparent. Simultaneously, minimally invasive glaucoma surgery platforms have expanded beyond traditional trabeculectomy, offering safer, more efficient drainage implants and micro-stents that shorten recovery times and reduce complication rates.

On the pharmaceutical front, the advent of Rho kinase inhibitors and fixed-dose combination drugs is diversifying treatment regimens and improving adherence, particularly among aging cohorts with multiple comorbidities. Remote monitoring technologies facilitate home-based intraocular pressure checks, integrating data into clinician dashboards for real-time intervention. The synergy of digital health, device innovation, and next-generation drugs signals a paradigm shift, positioning the glaucoma ecosystem for accelerated growth. Stakeholders who anticipate and align with these transformative trends will secure competitive advantage and deliver meaningful value in a rapidly evolving therapeutic landscape.

Assessing the Ripple Effects of New US Tariffs on Glaucoma Solutions

The introduction of new United States tariffs in 2025 has introduced additional complexity into the glaucoma supply chain, influencing both cost structures and procurement strategies. Devices such as optical coherence tomography systems, tonometers, and specialized surgical equipment often originate from global manufacturing hubs. Tariff increments on these key components have prompted OEMs to reevaluate sourcing, with some shifting production closer to end markets or negotiating long-term supply agreements to mitigate price volatility.

Pharmaceutical imports have experienced parallel pressures as excipients and active ingredients sourced abroad face elevated duties. Manufacturers are responding by diversifying their ingredient portfolios and accelerating domestic partnerships to ensure continuity of supply. Healthcare providers are also adapting procurement cycles and inventory management to buffer potential disruptions. While short-term cost pass-through to end users remains a concern, the industry’s proactive measures, including localized assembly and strategic stockpiling, are poised to stabilize access. Understanding the full ramifications of these tariff changes is essential for stakeholders to preserve margins and maintain uninterrupted patient care.

Unveiling Market Dynamics Across Product, End User, Distribution, and Administration

The glaucoma market can be dissected through multiple lenses, each revealing distinct growth drivers and competitive dynamics. When viewed by product type, diagnostic and monitoring devices take center stage with fundus cameras, optical coherence tomography platforms, pachymeters, perimetry suites, and tonometry systems collectively advancing early detection and progression tracking. Surgical solutions span from established trabeculectomy tools to innovative drainage implants, laser devices, and a burgeoning class of micro-invasive glaucoma surgery instruments, where Hydrus, IStent, and Xen Gel Stent have gained particular traction. Therapeutics encompass a broad spectrum of chemical classes, including alpha agonists, beta blockers, carbonic anhydrase inhibitors, combination therapies, miotics, prostaglandin analogues, and the emerging Rho kinase inhibitors that promise improved efficacy and tolerability.

In terms of end users, ambulatory surgical centers have capitalized on outpatient procedures, while home care settings leverage remote monitoring to empower patients. Hospitals maintain their role in complex interventions, and ophthalmic clinics continue to drive routine screening and early intervention. Distribution channels reveal distinct preferences, with hospital pharmacies facilitating in-hospital dispensing, online pharmacies providing convenience for chronic medication refills, and retail pharmacies serving as widespread access points. Finally, route of administration influences therapeutic strategy; intravenous options support acute care in hospitals, oral regimens cater to systemic compliance, and topical formulations remain the predominant choice for chronic management at home.

Regional Variations Driving Glaucoma Treatment Strategies

Geographic nuances play a pivotal role in shaping glaucoma care strategies. Across the Americas, a well-established reimbursement infrastructure and high rates of screening drive widespread adoption of advanced imaging and surgical interventions. In Europe, the Middle East, and Africa, diverse healthcare systems and variable regulatory frameworks lead to differentiated uptake, with some regions emphasizing cost-effective therapeutic generics while others invest heavily in cutting-edge diagnostics. Meanwhile, Asia-Pacific stands out for its rapidly aging populations and expanding healthcare access, with China, Japan, and India at the forefront of large-scale screening initiatives and local manufacturing expansions.

Regional clinical guidelines, economic factors, and patient awareness campaigns influence treatment patterns and technology adoption rates. Understanding these territorial distinctions enables market participants to tailor entry strategies, optimize product portfolios for specific regulatory environments, and forge partnerships that align with localized priorities. The synergy between global innovation and regional execution will determine which stakeholders capture emerging opportunities in each territory.

Competitive Landscape Highlights Leading Glaucoma Solution Providers

A select group of industry leaders is steering innovation and market growth in glaucoma diagnostics, devices, and therapeutics. Prominent ophthalmic device manufacturers have expanded their portfolios through strategic acquisitions and internal R&D, targeting seamless integration of imaging, monitoring, and surgical systems. Pharmaceutical companies are diversifying pipelines with next-generation pharmacologic classes and combination therapies, seeking regulatory approvals that address unmet needs in IOP control and neuroprotection.

Collaborations between medical device and digital health firms are accelerating the development of connected care ecosystems. Smaller specialized companies are carving niches with unique micro-invasive surgical implants or AI-enhanced diagnostic platforms. Across the competitive landscape, partnerships with academic institutions and clinical research networks underpin robust evidence generation and expedite market access. These top-tier players demonstrate a clear pattern of investing in end-to-end patient solutions, leveraging their scale to penetrate new markets and solidify leadership positions.

Strategic Pathways to Strengthen Market Position in Glaucoma Therapy

To capitalize on evolving market conditions, industry leaders should prioritize end-to-end integration of diagnostics, therapeutics, and patient support services. Investment in artificial intelligence and machine learning will enhance the predictive power of imaging data and enable personalized risk stratification. Diversifying manufacturing footprints and forging local partnerships can mitigate geopolitical and tariff-related risks, ensuring reliable supply chains.

Embracing value-based care models by collaborating with payers and healthcare systems will facilitate reimbursement for breakthrough therapies and minimally invasive procedures. Developing patient engagement platforms and remote monitoring capabilities can drive adherence and improve long-term outcomes. Moreover, pursuing targeted expansion in underserved regions through licensing agreements or joint ventures can unlock new growth corridors. By aligning R&D, commercial, and regulatory strategies with these actionable imperatives, organizations will be well-positioned to lead the next wave of glaucoma care innovation.

Rigorous Approach Underpinning Market Intelligence

This analysis is grounded in a rigorous research design that combines primary interviews with key opinion leaders in ophthalmology, device engineering, and pharmaceutical development, alongside secondary data collection from regulatory filings, clinical trial registries, and peer-reviewed literature. Data triangulation techniques were employed to validate market trends, while in-depth segmentation analysis provided clarity on discrete product, end-user, and geographic dynamics.

Market participant surveys offered insights into purchasing behaviors and technology adoption rates, while financial reports and patent databases informed competitive benchmarking. Expert panels reviewed preliminary findings to ensure accuracy and relevance, and methodological transparency was maintained through detailed documentation of assumptions, data sources, and analytical frameworks. This comprehensive approach underpins the credibility of the insights presented throughout this summary.

Synthesizing Insights to Illuminate Glaucoma Market Trajectory

The glaucoma market is at a critical juncture defined by rapid technological advances, shifting regulatory landscapes, and evolving patient expectations. Diagnostic innovations and minimally invasive surgeries are reshaping clinical pathways, while emerging therapeutics are broadening treatment options. Tariff developments have underscored the importance of strategic supply chain management, and regional nuances continue to dictate adoption rates and market access.

By synthesizing segmentation insights, competitive dynamics, and actionable recommendations, this report illuminates the pathways through which stakeholders can drive sustainable growth and patient value. The convergence of digital health, precision medicine, and collaborative partnerships heralds a new era in glaucoma care, one that rewards agility, foresight, and commitment to improving outcomes. With the right strategies in place, the next chapter of glaucoma management promises unprecedented potential for innovation and impact.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Diagnostic & Monitoring Devices
      • Fundus Cameras
      • Optical Coherence Tomography
      • Pachymeters
      • Perimetry Devices
      • Tonometry Devices
    • Surgical Devices
      • Glaucoma Drainage Implants
      • Laser Devices
      • Micro-Invasive Glaucoma Surgery Devices
        • Hydrus
        • IStent
        • Xen Gel Stent
      • Trabeculectomy Devices
    • Therapeutics
      • Alpha Agonists
      • Beta Blockers
      • Carbonic Anhydrase Inhibitors
      • Combination Drugs
      • Miotics
      • Prostaglandin Analogues
      • Rho Kinase Inhibitors
  • End User
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Hospitals
    • Ophthalmic Clinics
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Route Of Administration
    • Intravenous
    • Oral
    • Topical
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Novartis AG
  • AbbVie Inc.
  • Alcon Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Laboratoires Théa SAS
  • Sun Pharmaceutical Industries Ltd.
  • Glaukos Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Glaucoma Market, by Product Type
8.1. Introduction
8.2. Diagnostic & Monitoring Devices
8.2.1. Fundus Cameras
8.2.2. Optical Coherence Tomography
8.2.3. Pachymeters
8.2.4. Perimetry Devices
8.2.5. Tonometry Devices
8.3. Surgical Devices
8.3.1. Glaucoma Drainage Implants
8.3.2. Laser Devices
8.3.3. Micro-Invasive Glaucoma Surgery Devices
8.3.3.1. Hydrus
8.3.3.2. IStent
8.3.3.3. Xen Gel Stent
8.3.4. Trabeculectomy Devices
8.4. Therapeutics
8.4.1. Alpha Agonists
8.4.2. Beta Blockers
8.4.3. Carbonic Anhydrase Inhibitors
8.4.4. Combination Drugs
8.4.5. Miotics
8.4.6. Prostaglandin Analogues
8.4.7. Rho Kinase Inhibitors
9. Glaucoma Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Home Care Settings
9.4. Hospitals
9.5. Ophthalmic Clinics
10. Glaucoma Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
11. Glaucoma Market, by Route of Administration
11.1. Introduction
11.2. Intravenous
11.3. Oral
11.4. Topical
12. Americas Glaucoma Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Glaucoma Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Glaucoma Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Novartis AG
15.3.2. AbbVie Inc.
15.3.3. Alcon Inc.
15.3.4. Pfizer Inc.
15.3.5. Merck & Co., Inc.
15.3.6. Bausch Health Companies Inc.
15.3.7. Santen Pharmaceutical Co., Ltd.
15.3.8. Laboratoires Théa SAS
15.3.9. Sun Pharmaceutical Industries Ltd.
15.3.10. Glaukos Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. GLAUCOMA MARKET MULTI-CURRENCY
FIGURE 2. GLAUCOMA MARKET MULTI-LANGUAGE
FIGURE 3. GLAUCOMA MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GLAUCOMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GLAUCOMA MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GLAUCOMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GLAUCOMA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GLAUCOMA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GLAUCOMA MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GLAUCOMA MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GLAUCOMA MARKET SIZE, BY PACHYMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GLAUCOMA MARKET SIZE, BY PERIMETRY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GLAUCOMA MARKET SIZE, BY TONOMETRY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GLAUCOMA MARKET SIZE, BY GLAUCOMA DRAINAGE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GLAUCOMA MARKET SIZE, BY LASER DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GLAUCOMA MARKET SIZE, BY HYDRUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GLAUCOMA MARKET SIZE, BY ISTENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GLAUCOMA MARKET SIZE, BY XEN GEL STENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GLAUCOMA MARKET SIZE, BY TRABECULECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GLAUCOMA MARKET SIZE, BY ALPHA AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GLAUCOMA MARKET SIZE, BY BETA BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GLAUCOMA MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GLAUCOMA MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GLAUCOMA MARKET SIZE, BY MIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GLAUCOMA MARKET SIZE, BY PROSTAGLANDIN ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GLAUCOMA MARKET SIZE, BY RHO KINASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GLAUCOMA MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GLAUCOMA MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GLAUCOMA MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GLAUCOMA MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GLAUCOMA MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GLAUCOMA MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GLAUCOMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GLAUCOMA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GLAUCOMA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GLAUCOMA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 64. CANADA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 66. CANADA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 67. CANADA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 69. CANADA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. CANADA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. CANADA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 74. MEXICO GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 75. MEXICO GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. MEXICO GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. MEXICO GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. GERMANY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 115. GERMANY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 116. GERMANY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 117. GERMANY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 118. GERMANY GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. GERMANY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. GERMANY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 123. FRANCE GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 124. FRANCE GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 125. FRANCE GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. FRANCE GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. FRANCE GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 138. ITALY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 139. ITALY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 140. ITALY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 141. ITALY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 142. ITALY GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. ITALY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. ITALY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 145. SPAIN GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. SPAIN GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 147. SPAIN GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 148. SPAIN GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 149. SPAIN GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 150. SPAIN GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. SPAIN GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. SPAIN GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SOUTH AFRICA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. DENMARK GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. DENMARK GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. DENMARK GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 180. DENMARK GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 181. DENMARK GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 182. DENMARK GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. DENMARK GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. DENMARK GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. NETHERLANDS GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. NETHERLANDS GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. QATAR GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 195. QATAR GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 196. QATAR GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 197. QATAR GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 198. QATAR GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. QATAR GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. QATAR GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 201. FINLAND GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. FINLAND GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 203. FINLAND GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 204. FINLAND GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 205. FINLAND GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 206. FINLAND GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. FINLAND GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. FINLAND GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. NIGERIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. NIGERIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. EGYPT GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. EGYPT GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 227. EGYPT GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 228. EGYPT GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 229. EGYPT GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 230. EGYPT GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. EGYPT GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. EGYPT GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 233. TURKEY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 234. TURKEY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 235. TURKEY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 236. TURKEY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 237. TURKEY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 238. TURKEY GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. TURKEY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 240. TURKEY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 249. NORWAY GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 250. NORWAY GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 251. NORWAY GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 252. NORWAY GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 253. NORWAY GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 254. NORWAY GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. NORWAY GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. NORWAY GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 257. POLAND GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. POLAND GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 259. POLAND GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 260. POLAND GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 261. POLAND GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 262. POLAND GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. POLAND GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. POLAND GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SWITZERLAND GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. SWITZERLAND GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. ASIA-PACIFIC GLAUCOMA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 282. CHINA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. CHINA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 284. CHINA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 285. CHINA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 286. CHINA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 287. CHINA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. CHINA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. CHINA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 290. INDIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 291. INDIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 292. INDIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 293. INDIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 294. INDIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 295. INDIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. INDIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. INDIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. JAPAN GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 299. JAPAN GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 300. JAPAN GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 301. JAPAN GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 302. JAPAN GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 303. JAPAN GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. JAPAN GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. JAPAN GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. AUSTRALIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. AUSTRALIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 320. SOUTH KOREA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. SOUTH KOREA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. INDONESIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 329. INDONESIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 330. THAILAND GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 331. THAILAND GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 332. THAILAND GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 333. THAILAND GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 334. THAILAND GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 335. THAILAND GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. THAILAND GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 337. THAILAND GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 344. PHILIPPINES GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. PHILIPPINES GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 347. MALAYSIA GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 348. MALAYSIA GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 349. MALAYSIA GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 350. MALAYSIA GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 351. MALAYSIA GLAUCOMA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 352. MALAYSIA GLAUCOMA MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 353. MALAYSIA GLAUCOMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 354. SINGAPORE GLAUCOMA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 355. SINGAPORE GLAUCOMA MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
TABLE 356. SINGAPORE GLAUCOMA MARKET SIZE, BY SURGICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 357. SINGAPORE GLAUCOMA MARKET SIZE, BY MICRO-INVASIVE GLAUCOMA SURGERY DEVICES, 2018-2030 (USD MILLION)
TABLE 358. SINGAPORE GLAUCOMA MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 359. SINGAPORE GLA

Companies Mentioned

The companies profiled in this Glaucoma market report include:
  • Novartis AG
  • AbbVie Inc.
  • Alcon Inc.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Bausch Health Companies Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Laboratoires Théa SAS
  • Sun Pharmaceutical Industries Ltd.
  • Glaukos Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.04 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.57 Billion
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast to 2030 - Product Image

Glaucoma Surgery Devices Market by Procedure, Device, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 181 Pages
  • Global
From
Glaucoma Aqueous Shunt Device Market by Device Type, End User, Distribution Channel, Material - Global Forecast to 2030 - Product Image

Glaucoma Aqueous Shunt Device Market by Device Type, End User, Distribution Channel, Material - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Micro Invasive Glaucoma Surgery (MIGS) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Glaucoma Treatment Market By Disease Type, By Treatment, By End User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035 - Product Image

Glaucoma Treatment Market By Disease Type, By Treatment, By End User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

  • Report
  • 210 Pages
  • Global
From
Glaucoma Surgery Devices - Global Strategic Business Report - Product Image

Glaucoma Surgery Devices - Global Strategic Business Report

  • Report
  • 93 Pages
  • Global
From

About the Glaucoma Market

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss. Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.